Number of the records: 1
spondylartritída axiálna
SYS d000089183 LBL 00000cz--a2200181n--4500 005 20250606223310.1 008 220101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a C05.116.900.853.625.800.744 065 $a C05.550.069.340 065 $a C05.550.114.865.800.744 066 $a 01 $c 03 150 $a spondylartritída axiálna $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a AxSpA $2 eng 450 $w v $a spondyloartritída axiálna $2 slo 450 $w v $a AxSpA $2 slo 665 $a 2022 $2 eng 665 $a Spondylitis, Ankylosing (2006-2021) $2 eng 680 9-
$i A spectrum of chronic inflammatory conditions affecting the axial joints (e.g., SPINE), characterized by pain, stiffness of joints (ANKYLOSIS), reduced mobility and inflammation. When joint inflammation and damage are visible on regular X-rays it is called ANKYLOSING SPONDYLITIS; otherwise it is referred to as NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. HLA-B27 ANTIGEN is a biomarker and IL-23/IL-17 pathway a potential therapeutic target for axial and other related spondyloarthritis. $2 eng 680 $a general or unspecified; prefer specifics $2 eng 750 -2
$a Axial Spondyloarthritis $2 eng 980 $x M
Number of the records: 1